Vivos Therapeutics, Inc. (VVOS)

0.2666 -0.01 (-3.68%) USD  |  NASDAQ  |  Aug 25, 14:55
More

Vivos Therapeutics Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for VVOS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2024. Start Trial.
Date Value
August 19, 2026 --
July 08, 2026 --
June 30, 2026 --
June 04, 2026 --
May 27, 2026 --
April 22, 2026 --
April 20, 2026 --
April 17, 2026 --
March 31, 2026 --
December 31, 2025 --
December 03, 2025 --
December 02, 2025 --
Date Value
November 17, 2025 --
November 14, 2025 --
September 30, 2025 --
September 09, 2025 --
August 21, 2025 --
May 20, 2025 --
April 15, 2025 --
April 01, 2025 --
March 31, 2025 --
November 19, 2024 --
August 20, 2024 --
August 19, 2024 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Hinge Health, Inc. Upgrade
Exlites Holdings International, Inc. --
Xcelerate, Inc. --
Haemonetics Corp. Upgrade
Pro-Dex, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Next Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade